These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34729053)

  • 1. Downregulation of Src-family tyrosine kinases by Srcasm and c-Cbl: A comparative analysis.
    Lee V; Griffin TD; Suzuki-Horiuchi Y; Wushanley L; Kweon Y; Marshall C; Li W; Ayli E; Haimovic A; Hines A; Seykora JT
    J Carcinog; 2021; 20():21. PubMed ID: 34729053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Srcasm inhibits Fyn-induced cutaneous carcinogenesis with modulation of Notch1 and p53.
    Zhao L; Li W; Marshall C; Griffin T; Hanson M; Hick R; Dentchev T; Williams E; Werth A; Miller C; Bashir H; Pear W; Seykora JT
    Cancer Res; 2009 Dec; 69(24):9439-47. PubMed ID: 19934324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Srcasm corrects Fyn-induced epidermal hyperplasia by kinase down-regulation.
    Li W; Marshall C; Mei L; Gelfand J; Seykora JT
    J Biol Chem; 2007 Jan; 282(2):1161-9. PubMed ID: 17046829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Srcasm modulates EGF and Src-kinase signaling in keratinocytes.
    Li W; Marshall C; Mei L; Dzubow L; Schmults C; Dans M; Seykora J
    J Biol Chem; 2005 Feb; 280(7):6036-46. PubMed ID: 15579470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Srcasm: a novel Src activating and signaling molecule.
    Seykora JT; Mei L; Dotto GP; Stein PL
    J Biol Chem; 2002 Jan; 277(4):2812-22. PubMed ID: 11711534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased Srcasm expression in esophageal squamous cell carcinoma in a Chinese population.
    Qi Y; Li X; Zhao L; Seykora JT
    Anticancer Res; 2010 Sep; 30(9):3535-9. PubMed ID: 20944134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of Csk preferentially reduces the protein level of LynA in a Cbl-dependent manner in cancer cells.
    Kuga T; Yamane Y; Hayashi S; Taniguchi M; Yamaguchi N; Yamagishi N
    Sci Rep; 2020 May; 10(1):7621. PubMed ID: 32376886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased Srcasm expression in hyperproliferative cutaneous lesions.
    Meulener MC; Ayli EE; Elenitsas R; Seykora JT
    J Cutan Pathol; 2009 Mar; 36(3):291-5. PubMed ID: 19220627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Cbl proto-oncogene product negatively regulates the Src-family tyrosine kinase Fyn by enhancing its degradation.
    Andoniou CE; Lill NL; Thien CB; Lupher ML; Ota S; Bowtell DD; Scaife RM; Langdon WY; Band H
    Mol Cell Biol; 2000 Feb; 20(3):851-67. PubMed ID: 10629042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An essential role of ubiquitination in Cbl-mediated negative regulation of the Src-family kinase Fyn.
    Rao N; Ghosh AK; Douillard P; Andoniou CE; Zhou P; Band H
    Signal Transduct; 2002 Nov; 2(1-2):29-39. PubMed ID: 19966925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRAF6 protein couples Toll-like receptor 4 signaling to Src family kinase activation and opening of paracellular pathway in human lung microvascular endothelia.
    Liu A; Gong P; Hyun SW; Wang KZ; Cates EA; Perkins D; Bannerman DD; Puché AC; Toshchakov VY; Fang S; Auron PE; Vogel SN; Goldblum SE
    J Biol Chem; 2012 May; 287(20):16132-45. PubMed ID: 22447928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CBL mutation-related patterns of phosphorylation and sensitivity to tyrosine kinase inhibitors.
    Makishima H; Sugimoto Y; Szpurka H; Clemente MJ; Ng KP; Muramatsu H; O'Keefe C; Saunthararajah Y; Maciejewski JP
    Leukemia; 2012 Jul; 26(7):1547-54. PubMed ID: 22246246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of endothelin-1 on Src-family tyrosine kinases and Na,K-ATPase activity in porcine lens epithelium.
    Mandal A; Shahidullah M; Beimgraben C; Delamere NA
    J Cell Physiol; 2011 Oct; 226(10):2555-61. PubMed ID: 21792912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation.
    Kaabeche K; Lemonnier J; Le Mée S; Caverzasio J; Marie PJ
    J Biol Chem; 2004 Aug; 279(35):36259-67. PubMed ID: 15190072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential requirement for Src family tyrosine kinases in the initiation, progression, and metastasis of prostate cancer.
    Gelman IH; Peresie J; Eng KH; Foster BA
    Mol Cancer Res; 2014 Oct; 12(10):1470-9. PubMed ID: 25053806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical basis for the requirement of kinase activity for Cbl-dependent ubiquitinylation and degradation of a target tyrosine kinase.
    Ghosh AK; Reddi AL; Rao NL; Duan L; Band V; Band H
    J Biol Chem; 2004 Aug; 279(34):36132-41. PubMed ID: 15208330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A juxtamembrane tyrosine in the colony stimulating factor-1 receptor regulates ligand-induced Src association, receptor kinase function, and down-regulation.
    Rohde CM; Schrum J; Lee AW
    J Biol Chem; 2004 Oct; 279(42):43448-61. PubMed ID: 15297464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel non-catalytic mechanism employed by the C-terminal Src-homologous kinase to inhibit Src-family kinase activity.
    Chong YP; Mulhern TD; Zhu HJ; Fujita DJ; Bjorge JD; Tantiongco JP; Sotirellis N; Lio DS; Scholz G; Cheng HC
    J Biol Chem; 2004 May; 279(20):20752-66. PubMed ID: 14985335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Srcasm overexpression in psoriasis-insights into pathogenesis.
    Pulitzer M; Li W; Hanson M; Singh F; Elenitsas R; Gelfand JM; VanVoorhees A; Seykora JT
    J Cutan Pathol; 2007 Feb; 34(2):160-5. PubMed ID: 17244028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency of Fyn protein is prerequisite for apoptosis induced by Src family kinase inhibitors in human mesothelioma cells.
    Eguchi R; Kubo S; Takeda H; Ohta T; Tabata C; Ogawa H; Nakano T; Fujimori Y
    Carcinogenesis; 2012 May; 33(5):969-75. PubMed ID: 22354875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.